Evaluation of the Efficacy and Safety of Different Duration of Proton Pump Inhibitor for Prevention of Upper Gastrointestinal Mucosal Injury in Patients Taking 12-month Dual Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery
Status: Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 10 Apr 2019
Price : $35 *
At a glance
- Drugs Pantoprazole (Primary)
- Indications Gastric ulcer
- Focus Adverse reactions
- Acronyms DACAB-GI-2
- 05 Apr 2019 Planned End Date changed from 1 Sep 2020 to 1 Dec 2020.
- 05 Apr 2019 Planned primary completion date changed from 1 Sep 2019 to 1 Sep 2020.
- 05 Apr 2019 Status changed from not yet recruiting to withdrawn prior to enrolment.